Literature DB >> 21084846

Factors affecting islet graft embolization in the liver of diabetic mice.

Naoki Sakata1, Andre Obenaus, Nathaniel Chan, John Mace, Richard Chinnock, Eba Hathout.   

Abstract

BACKGROUND: Embolic occlusion of the portal vein due to islet transplantation is one of the major reasons for reduced survival of transplanted islets. In this study, we examined the location of islets as well as the correlation between islet and portal vein size after intraportal islet transplantation, and evaluated liver and islet pathology.
METHODS: BALB/c mice were intraportally transplanted with 800 islets and the liver was examined at postoperative day (POD) 0 (n=7), POD 2 (n=4) and POD 28 (n=3). Liver specimens were stained for hematoxylin and eosin (necrosis), insulin, and TUNEL (apoptosis). We evaluated distance from liver surface to islets, islet and portal vein diameter, embolic ratio (islet diameter/portal vein diameter), apoptosis/necrosis of islets and apoptosis/necrosis of the liver tissue surrounding the islet.
RESULTS: The liver was divided into peripheral and central sites. Islet and liver apoptosis/necrosis were significantly higher at peripheral sites. In regions without liver apoptosis or necrosis, portal vein diameter was significantly larger and embolic ratios were significantly lower.
CONCLUSION: Transplanted islets and liver tissue exhibited more injury at peripheral sites, in part, due to smaller diameters of portal venules that result in more frequent emboli following islet transplantation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 21084846     DOI: 10.4161/isl.1.1.8563

Source DB:  PubMed          Journal:  Islets        ISSN: 1938-2014            Impact factor:   2.694


  7 in total

1.  The co-transplantation of bone marrow derived mesenchymal stem cells reduced inflammation in intramuscular islet transplantation.

Authors:  Gumpei Yoshimatsu; Naoaki Sakata; Haruyuki Tsuchiya; Takashi Minowa; Taro Takemura; Hiromi Morita; Tatsuo Hata; Masahiko Fukase; Takeshi Aoki; Masaharu Ishida; Fuyuhiko Motoi; Takeshi Naitoh; Yu Katayose; Shinichi Egawa; Michiaki Unno
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

2.  Oxygenation of the Intraportally Transplanted Pancreatic Islet.

Authors:  Thomas M Suszynski; Efstathios S Avgoustiniatos; Klearchos K Papas
Journal:  J Diabetes Res       Date:  2016-10-30       Impact factor: 4.011

3.  Pleckstrin homology-like domain family A, member 3 (PHLDA3) deficiency improves islets engraftment through the suppression of hypoxic damage.

Authors:  Naoaki Sakata; Yohko Yamaguchi; Yu Chen; Masayuki Shimoda; Gumpei Yoshimatsu; Michiaki Unno; Shoichiro Sumi; Rieko Ohki
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

Review 4.  The Spleen as an Optimal Site for Islet Transplantation and a Source of Mesenchymal Stem Cells.

Authors:  Naoaki Sakata; Gumpei Yoshimatsu; Shohta Kodama
Journal:  Int J Mol Sci       Date:  2018-05-07       Impact factor: 5.923

5.  Possibility of adiponectin use to improve islet transplantation outcomes.

Authors:  Naoaki Sakata; Gumpei Yoshimatsu; Kiyoshi Chinen; Ryo Kawakami; Shohta Kodama
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

Review 6.  Imaging of transplanted islets by positron emission tomography, magnetic resonance imaging, and ultrasonography.

Authors:  Naoaki Sakata; Gumpei Yoshimatsu; Haruyuki Tsuchiya; Takeshi Aoki; Masamichi Mizuma; Fuyuhiko Motoi; Yu Katayose; Tetsuya Kodama; Shinichi Egawa; Michiaki Unno
Journal:  Islets       Date:  2013-11-14       Impact factor: 2.694

7.  Integrated whole liver histologic analysis of the allogeneic islet distribution and characteristics in a nonhuman primate model.

Authors:  Geun Soo Kim; Jong Hyun Lee; Du Yeon Shin; Han Sin Lee; Hyojun Park; Kyo Won Lee; Heung-Mo Yang; Sung Joo Kim; Jae Berm Park
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.